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The P-type ATPase inhibiting potential
of polyoxotungstates†
Nadiia Gumerova, a Luka´sˇ Krivosudsky´, ‡a Gil Fraqueza, bc
Joscha Breibeck, a Emir Al-Sayed, a Elias Tanuhadi, a Aleksandar Bijelic, a
Juan Fuentes, b Manuel Aureliano *bd and Annette Rompel *a
Polyoxometalates (POMs) are transition metal complexes that exhibit a broad diversity of structures and
properties rendering them promising for biological purposes. POMs are able to inhibit a series of
biologically important enzymes, including phosphatases, and thus are able to aﬀect many biochemical
processes. In the present study, we analyzed and compared the inhibitory eﬀects of nine diﬀerent
polyoxotungstates (POTs) on two P-type ATPases, Ca2+-ATPase from skeletal muscle and Na+/K+-ATPase
from basal membrane of skin epithelia. For Ca2+-ATPase inhibition, an in vitro study was performed and
the strongest inhibitors were determined to be the large heteropolytungstate K9(C2H8N)5[H10Se2W29O103]
(Se2W29) and the Dawson-type POT K6[a-P2W18O62] (P2W18) exhibiting IC50 values of 0.3 and 0.6 mM,
respectively. Promising results were also shown for the Keggin-based POTs K6H2[CoW11TiO40] (CoW11Ti,
IC50 = 4 mM) and Na10[a-SiW9O34] (SiW9, IC50 = 16 mM), K14[As2W19O67(H2O)] (As2W19, IC50 = 28 mM) and
the lacunary Dawson K12[a-H2P2W12O48] (P2W12, IC50 = 11 mM), whereas low inhibitory potencies were
observed for the isopolytungstate Na12[H4W22O74] (W22, IC50 = 68 mM) and the Anderson-type
Na6[TeW6O24] (TeW6, IC50 = 200 mM). Regarding the inhibition of Na
+/K+-ATPase activity, for the first
time an ex vivo study was conducted using the opercular epithelium of killifish in order to investigate the
eﬀects of POTs on the epithelial chloride secretion. Interestingly, 1 mM of the most potent Ca2+-ATPase
inhibitor, Se2W29, showed only a minor inhibitory eﬀect (14% inhibition) on Na
+/K+-ATPase activity,
whereas almost total inhibition (99% inhibition) was achieved using P2W18. The remaining POTs exhibited
similar inhibition rates on both ATPases. These results reveal the high potential of some POTs to act as
P-type ATPase inhibitors, with Se2W29 showing high selectivity towards Ca
2+-ATPase.
Significance to metallomics
We studied the inhibitory eﬀects of nine diﬀerent polyoxotungstates (POTs) on P-type ATPases in vitro (Ca+-ATPase) and ex vivo (Na+/K+-ATPase). The study
reveals that some POTs like the Dawson anion [P2W18O62]
6, which was highly active in vitro and ex vivo, are potent ATPase inhibitors. Furthermore, there is a
charge density-activity correlation for the most potent POTs (IC50 o 16 mM), namely Se2W29, P2W18, CoW11Ti, SiW9 and P2W12. As P-type ATPases represent
pharmacologically important targets due to their important role in health and disease, the here reported bioactive POTs should be considered as possible
future metallodrugs.
Introduction
Polyoxometalates (POMs) are metal clusters1 that exhibit a
broad diversity of structures and outstanding properties leading
to their application in various fields such as catalysis,2,3 photo-
chemistry,4 material science,5,6 macromolecular crystallography7–15
and medicine.16–22 POMs can be divided into isopolyanions (IPAs),
which consist only of one type of metal atom (M = addenda atom),
[MmOy]
q, and heteropolyanions (HPAs), which contain one or
more additional elements (X = heteroatom), [XrMmOy]
q. The
most common representative of IPAs is the Lindqvist structure,
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whereas the well-known Dawson, Keggin and Anderson archetypes
belong to the HPAs (Fig. 1). POM research represents an emerging
field and especially bioactive POMs are getting more and more
attractive due to their ability to interact with important enzymes
like alkaline phosphatases, ecto-nucleotidases and ATPases and
their potential to interfere with specific cellular processes, such
as mitochondria respiration.21–24 POMs like decavanadate or
Keggin-type polyoxotungstates (POTs) and polyoxomolybdates are
currently the focus of biological and biomedical research as they
show promising antibacterial and antidiabetic activities,21,22,24–28
whereas only few biological studies exist for other POM archetypes
such as the Anderson structure.29
The main role of the sarcoplasmic reticulum (SR) Ca2+-ATPase
is translocation of cellular Ca2+ from the cytoplasm to the SR,
which is involved inmuscle relaxation.30,31 However, Ca2+-ATPase
is globally associated with cellular calcium homeostasis, a pro-
cess of ion transport that is coupled with ATP hydrolysis. ATP
hydrolysis follows a well-known mechanism traversing at least
four intermediate steps and two protein conformations, namely
E1 and E2, with E1 being the conformation with high aﬃnity for
the exported substrate and E2 the form with high aﬃnity for the
imported substrate.30,31 As SR vesicles from skeletal muscle
contain a large amount of Ca2+-ATPase, they represent a useful
in vitromodel to study the eﬀects of drugs and POMs on calcium
homeostasis.32,33 To our knowledge, only a few POMs, such as
decavanadate (V10) and decaniobate (Nb10), were described to be
potent non-competitive inhibitors (IC50 = 15 and 35 mM, respectively)
of the hydrolytic activity of SR Ca2+-ATPase.33 Na+/K+-ATPase
transports Na+ out of the cell while pumping K+ into cells and is
thus responsible for the ionic and osmotic balance in cells and
an important transducer of signals. As all P-type ATPases, the
Na+/K+ pump derives energy from ATP hydrolysis.
Herein, we report and compare the eﬀects of nine diﬀerent
POTs (Fig. 1 and Table 1) on the in vitro activity of Ca2+-ATPase
from SR. For the first time, we investigate the eﬀects of POTs on
the process of epithelial chloride secretion, energized by the
activity of basolateral Na+/K+-ATPase, using an ex vivo model
obtained from basal membrane of epithelial skin (killifish).
Putative correlations between the inhibitory activity of POTs
(IC50 values), their charge density and size were derived. The
results reveal that some POTs are potent inhibitors of P-type
ATPases even under almost physiological conditions (ex vivo study)
and therefore should be taken into consideration as P-type ATPase
targeting drugs. One POT, namely K9(C2H8N)5[H10Se2W29O103]
(Se2W29) showed clear selectivity towards one pump (Ca
2+-
ATPase), whereas other POTs like the Anderson archetype
Na6[TeW6O24] showed very low inhibition on both ion pumps.
Experimental section
Polyoxometalates
The POTs used in this study, K6[a-P2W18O62]14H2O,35 Na6-
[TeW6O24]22H2O,36 K6H2[TiW11CoO40]13H2O,37 Na10[a-SiW9O34]
16H2O,
35 Na9[a-AsW9O33]27H2O,38 K12[a-H2P2W12O48]16H2O,35
K14[As2W19O67(H2O)]23H2O,39 K9(C2H8N)5[H10Se2W29O103]30H2O40
and Na12[H4W22O74]50H2O41 (Table 1 and Fig. 1), were synthe-
sized according to published procedures (see references in
Table 1) and their identity was confirmed by infrared spectro-
scopy. Stock solutions of POTs were freshly prepared by dissolving
the solid compound in water and keeping the solution on ice to
avoid POT decomposition. The concentrations of the stock
solutions were 10 mM and 1 mM for all POTs except for
Se2W29 (1 mM and 0.1 mM).
Preparation of sarcoplasmic reticulum Ca2+-ATPase vesicles
All reagents used for the preparation of the calcium pump
vesicles were purchased from Sigma-Aldrich (Portugal). Isolated
sarcoplasmic reticulum vesicles (SRVs), prepared from rabbit
skeletal muscles as described elsewhere,33 were suspended in
Fig. 1 Structures of the investigated POTs (Table 1) and [V10O28]
6. Color
code: WO6, blue polyhedra; VO6, dark yellow polyhedra; heteroatom, light
yellow sphere or polyhedra; Ti as substituted atom, green sphere.
Table 1 Structural/molecular features of the POTs used in this study
POTs (abbreviated) Sum formula Mr Charge POT archetype Ref.
P2W18 K6[a-P2W18O62]14H2O 4849.83 6 Dawson 35
TeW6 Na6[TeW6O24]22H2O 2148.56 6 Anderson-Evans 36
CoW11Ti K6H2[TiW11CoO40]13H2O 3239.62 8 Mono-substituted Keggin 37
AsW9 Na9[B-a-AsW9O33]27H2O 2950.37 9 Tri-lacunary Keggin 38
SiW9 Na10[A-a-SiW9O34]16H2O 2744.52 10 Tri-lacunary Keggin 35
P2W12 K12[a-H2P2W12O48]16H2O 3795.19 12 Lacunary Dawson 35
As2W19 K14[As2W19O67(H2O)]23H2O 5694.15 14 Doubled anion based on tri-lacunary Keggin anions 39
Se2W29 K9(C2H8N)5[H10Se2W29O103]30H2O 8270.09 14 Lacunary anion based on two tri-lacunary Keggin anions
containing {(WO7)W4} pentagonal unit
40
W22 Na12[H4W22O74]50H2O 6409.10 12 Dimeric isopolyanion based on two {W11} units 41
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0.1 M KCl, 10 mM HEPES (pH 7.0), diluted 1 : 1 with 2.0 M
sucrose and frozen in liquid nitrogen for storage at 80 1C. The
protein concentration was determined spectrophotometrically
at 595 nm in the presence of 0.125% of sodium dodecyl
sulphate (SDS) by Bradford method with bovine serum albumin
as a standard. The percentage of each protein present in the
SRV preparations was determined by densitometry analysis of
SDS-PAGE (7.5% acrylamide) protein bands. The SR Ca2+-ATPase
constituted at least 70% of the total protein amount in the
SR-vesicles according to SDS-PAGE. The sarcoplasmic reticulum
Ca2+-ATPase-1 (SERCA-1) was the predominant isoform in our
SR preparations.42
Eﬀects of POTs on ATP hydrolysis of SR Ca2+-ATPase
Steady-state assays of the SR Ca2+-ATPase were measured spectro-
photometrically at 25 1C using the coupled enzyme pyruvate
kinase/lactate dehydrogenase assay (Scheme 1) as described
elsewhere.42 Briefly, after the addition of the enzymes (pyruvate
kinase and lactate dehydrogenase) and the substrate phos-
phoenolpyruvate to the medium, the experiment was initiated
by adding NADH (0.25 mM) and the vesicles containing
Ca2+-ATPase (10 mg mL1).
ATP (2.5 mM) was added and the absorbance was recorded
for about 1 minute (basal activity). Afterwards, the calcium
ionophore calcimycin 4% (w/w), which releases again the Ca2+
ions, that were pumped in by the ATPase, was added and the
decreasing NADH absorbance at 340 nm was measured for
about 2 minutes (uncoupled ATPase activity). This was done to
increase the ATPase activity (due to the ionophore-mediated
impairment of the Ca2+ gradient) in order to better study the
eﬀect of the inhibitors and to ensure that the SR Ca2+-ATPase
vesicles are not leaky. For the experiments including POTs,
freshly prepared POT solutions (10 mM and 1 mM for all POTs
except for Se2W29 1 mM and 0.1 mM) were added to the
medium prior to the addition of SR Ca2+-ATPase. The ATPase
activity and its inhibition was measured taking into account the
decrease of the OD (optical density) per minute in the absence
(100%) and in the presence of the investigated POTs.33 The
detection system was not aﬀected by the POTs themselves (not
even at their highest concentrations), which was confirmed by a
rapid decrease in absorbance at 340 nm upon addition of
40 mM ADP after the assay. All experiments were performed at
least in triplicates. The inhibitory power of the investigated
POTs was evaluated by determining the respective IC50 value,
that is, the POT concentration needed to induce a 50%
inhibition of the Ca2+-ATPase enzyme activity.
Animals used for ex vivo studies
Killifish (F. heteroclitus, 4–8 g) were collected with fish traps
from the saltmarshes of Ria Formosa (Faro, Portugal) and
maintained in Ramalhete Marine Station (CCMar, University
of Algarve, Faro, Portugal) with running seawater (35 ppt) at a
density of o5 kg m3, 18–20 1C and 12 : 12 h light : dark
photoperiod. The animals were handfed twice daily (final ratio
of 2% of the body weight) with commercially available dry
pellets (Sorgal, Portugal). The fishes were then food deprived
for 24 h before sampling. The animal collections (ICN, Portugal)
and the experimental procedures comply with the guidelines of
the European Union Council (86/609/EU) for the use of laboratory
animals. All animal protocols were performed under a ‘‘Group C’’
license from the Direcça˜o-Geral de Veterina´ria, Ministe´rio da
Agricultura, do Desenvolvimento Rural e das Pescas, Portugal.
Epithelial short circuit current in Ussing chambers ex vivo
Epithelial tissues can transport ions and generate a transepithelial
voltage termed ‘‘active transport potential’’, which is caused by the
asymmetric distribution of ion channels and transporters on the
apical and basolateral membranes. The net movement of charges
from the apical to the basolateral side (and vice versa) generates a
voltage equal to the voltage diﬀerences between the apical and
basolateral membranes. Ex vivo, the short circuit current (Isc) is an
accurate reflection of the secretory/absorptive capacity of the tissue
when short-circuited. In the opercular epithelium of killifish used
for our studies, Isc is a direct measure of apical chloride
secretion mediated by chloride channels, which relies on an
intact basolateral Na+/K+-ATPase function.43,44
Methodology for the ex vivo opercular epithelia preparation
followed our current methods.45 Fish were anaesthetized with
2-phenoxyethanol (1 : 2000 v/v), sacrificed by decapitation and
the cranium was cut longitudinally. The gills and other tissue
remains were removed carefully and the epithelial skin covering
the opercular bone were dissected out and transferred to fresh-
gassed saline (99.7 : 0.3 O2/CO2) with the following composition
(all values in mM): NaCl, 160; MgSO4, 0.93; NaH2PO4, 3.0; CaCl2,
1.5; NaHCO3, 17.85; KCl, 3.0; glucose, 5.5; HEPES (pH 7.8), 5.0.
The epithelia were overlaid onto a thin bore polythene net,
protected between two parafilm gaskets and pinned over the
circular aperture of a tissue holder (P2410, 0.20 cm2, Physiological
Instruments, San Diego, USA), with the perimeter area lightly
greased with vacuum silicone to minimize tissue edge damage.
The mounted tissue was positioned between the two halves of
the Ussing chamber (P2400, Physiological Instruments, San
Diego, USA) with 4 mL of gassed saline at 22 1C and gassed
with a 99.7 : 0.3 O2/CO2 mix to provide oxygenation, good mixing
by gas lift and pH control (pH = 7.8).
The preparations were left to stand for at least 60 min or
until a steady basal measurement of bioelectrical variables was
achieved. Measurement of the short circuit current (Isc, mA cm
2)
was performed at symmetric conditions under voltage clamp
Scheme 1 Coupled enzymatic assay for Ca2+-ATPase activity. PEP –
phosphoenolpyruvate; Pi – inorganic phosphate.
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to 0 mV. The open circuit potential (Vt, mV) and Isc were
monitored by means of Ag/AgCl electrodes connected to the
chambers by 3 mm bore agar bridges (1 M KCl in 3% agar).
Clamping of epithelia to 0 mV and recording of Isc was
performed by VCC600 voltage clamp amplifiers (Physiologic
Instruments, San Diego, USA). Epithelial resistance (Rt, O cm
2)
was manually calculated (Ohm’s law) using the current deflections
induced by bilateral 1 mV pulses of 3 s every minute. Bioelectrical
data were continuously digitized through a Lab-Trax-4 (WPI,
Sarasota, US) onto a Macbook laptop using Labscribe3 Software
(Iworks systems, Dover, US). Upon signal baseline stabilization,
freshly prepared POT solutions were added to the basal or
the apical side of the chamber (Fig. 2) and the eﬀects on the
Na+/K+-ATPase from basal membrane or the chloride channel
forming the apical membrane were followed for 60 to 90 minutes.
The maximum inhibitory eﬀect (in %) of the POTs on the ATPase
activity and the eﬀective time (ET50), which is the time necessary
to reach 50% of the maximum eﬀects (in minutes), was
determined by measuring the % decrease of short circuit
current (Isc, mA cm
2) in the absence (100% activity) and
presence of the POTs. All the experiments were performed at
least in triplicates. Calculations of the ET50 and maximum eﬀect
values were performed using GraphPad Prism version 6.00 for
Macintosh (GraphPad Software, La Jolla California USA).
Results and discussion
Inhibition of Ca2+-ATPase by POTs: in vitro study
The eﬀect of nine diﬀerent POTs (Fig. 1 and Table 1) on the
activity of SR Ca2+-ATPase from skeletal muscle was investigated for
the first time. All of the investigated POTs inhibited Ca2+-ATPase
activity in a concentration dependent manner. The inhibitory power
of the investigated POTs was finally evaluated using IC50 values
(Table 2). As shown in Table 2, diﬀerent IC50 values in the mM range
were determined for the various POT archetypes exhibiting diﬀerent
negative charges (Fig. 1 and Table 1). IC50 values of o1 mM were
determined for the Dawson anion P2W18 (0.6 mM, Fig. 3) and the
larger POT Se2W29 (IC50 = 0.3 mM), whereas the lowest inhibition
values were observed for the isopolyanion W22 (IC50 = 68 mM) and
the Anderson type TeW6 (IC50 = 200 mM). The remaining POTs
exhibited IC50 values in the range of 1 up to 28 mM (Table 2).
Similar moderate IC50 values for SR Ca
2+-ATPase activity
were previously reported for two isostructural polyanions,
decaniobate [Nb10O28]
6 (IC50 = 35 mM) and decavanadate
[V10O28]
6 (IC50 = 15 mM).
33,46 Both decaniobate and decavanadate
showed a non-competitive inhibition for Ca2+-ATPase activity
Fig. 2 Graphic representation of the experimental setup of the opercular
epithelium of killifish used for ex vivo studies. Isc was measured in voltage
clamp, and in this model represents chloride secretion. The process is
energized by basolateral Na+/K+-ATPase and chloride is secreted apically
via a chloride channel. In this polarised epithelium, both mechanisms are
required to be intact to sustain the process of secretion.
Table 2 Inhibitory parameters of the POTs for SR Ca2+-ATPase (IC50
values) activity and Na+/K+-ATPase activity from basal membrane epithelia
(eﬀective time 50 ET50 and maximum inhibitory eﬀects are calculated as
the % of basal values). Inhibitory eﬀect of diﬀerent POTs applied basolaterally
to the ex vivo preparation of the opercular epithelia of killifish mounted in
Ussing chambers. Results are representative values for 3 independent
experiments for each concentration (nd: not determined as no eﬀect was
observed after 30 minutes upon POT addition). Data showing the eﬀect of
ouabain for the Na+/K+-ATPase inhibition is included as a positive control for
the ex vivo system
POTs Ca2+-ATPase Na+/K+-ATPase
Compound
name IC50, (mM)
ET50, (min (depending
on concentration of
compound))
Maximum
inhibition, (%)
P2W18 0.6 8.2 (0.5 mM) 86
6.5 (1 mM) 99
4.3 (10 mM) 100
TeW6 200 60 (10 mM) 10
CoW11Ti 4 10 (10 mM) 75
SiW9 16 nd nd
P2W12 11 nd nd
As2W19 28 nd nd
Se2W29 0.3 6.5 (1 mM) 14
W22 68 nd nd
AsW9 20 8.5 (10 mM) 66
Ouabain — 3.2 (10 mM) 100
Fig. 3 Inhibition of Ca2+-ATPase activity by P2W18. Ca
2+-ATPase was
determined spectrophotometrically at 340 nm and 25 1C, using the coupled
enzyme pyruvate kinase/lactate dehydrogenase assay. The experiments
were initiated by the addition of 10 mg mL1 Ca2+-ATPase, in the presence
or absence of 4% (w/w) of the calcium ionophore calcimycin. Data are
plotted as means  SD and fit to the equation y = 73.126x2  133.62x +
103.45 (R2 = 0.9424).
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regarding the natural ligand MgATP.33 Thus, to further investigate
the kind of interactions between the POTs and ATPase, the type of
inhibition was determined for P2W18 and TeW6. It was observed
that both P2W18 (data not shown) and TeW6 exhibited amixed type
inhibition suggesting that they can interact with the substrate-
bound form of Ca2+-ATPase (Fig. 4). The binding site of V10 on
Ca2+-ATPase was previously described, which involves at least
three protein domains, including the phosphorylation and the
nucleotide binding sites.47
Inhibition of Na+/K+-ATPase by POTs: ex vivo study
POTs were added to the basolateral side of epithelia (Fig. 2) to
characterize their eﬀects on the Na+/K+-ATPase activity. The
obtained results, which are summarized in Table 2, revealed
inhibition rates ranging from only 10% for TeW6 (at 10 mM) to
almost 100% for P2W18 (at 1 and 10 mM).
It should be noted that the heteropoly POTs SiW9, P2W12,
As2W19 as well as the isopoly POTW22 showed no eﬀect on ATPase
activity after 30 minutes upon addition of 10 mM compound.
In order to further characterize the inhibitory eﬀects of the
investigated POTs on Na+/K+-ATPase, we calculated themaximum
inhibitory eﬀects with respect to the basal values. In addition, we
calculated the eﬀective time (ET50), defined as the time necessary
to achieve 50% of the maximum eﬀect, to have a measure for the
inhibitory dynamics of the individual POTs (Fig. 5). In Fig. 5 a
constant height of the current deflections used to calculate the
tissue resistance can be observed, indicating that the ex vivo
preparations retained their integrity and selectivity before and
after POT exposure. Therefore, since no changes were observed
on the tissue resistance (i.e. tissue integrity) all observed eﬀects of
POT on the epithelial function are due to changes of the short
circuit current (Isc). Modification of Isc provides an immediate
read-out of inhibitory/stimulatory eﬀects on either the apical
chloride channel or the basolateral Na+/K+-ATPase (Fig. 2). For
example, AsW9 (at 10 mM) exhibits a maximum inhibition of 66%
of the basal current and an ET50 value of 8.5 min (Fig. 5). It
has to be noted that both the maximum inhibitory eﬀect
(providing information about inhibitor eﬃcacy) and ET50
(providing information about inhibition velocity) are necessary
to define the biological eﬀects of POTs (Fig. 5 and Table 2). For
the ex vivo studies, a positive control experiment was performed
with the conventional Na+/K+-ATPase inhibitor ouabain.43,49
Ouabain (at 10 mM) showed a maximum inhibition value of
100% and an ET50 of 3.2 minutes (Fig. S1, ESI†). By inhibiting
the basolateral Na+/K+-ATPase activity, ouabain concomitantly
prevents apical chloride secretion in the studied epithelia
model as this process is energized by Na+/K+-ATPase.43,49
The addition of POTs to apical saline had no eﬀect on Isc and
therefore ruling out chloride channels as putative POT targets,
at least at POT concentrations up to 10 mM. The largest POT
(in terms of volume and number of addenda atoms) under
investigation, Se2W29, exhibited the highest inhibition (IC50 =
0.3 mM) of SR Ca2+-ATPase activity during the in vitro study.
However, used at the same concentration (1 mM), it was one of
the weakest inhibitors (14% inhibition; Table 2 and Fig. 6) for
the Na+/K+-ATPase activity during the ex vivo study. In contrast,
P2W18 eﬃciently inhibited both the SR Ca
2+-ATPase in vitro
(IC50 = 0.6 mM) and the Na
+/K+-ATPase ex vivo (99% inhibition)
(Table 2 and Fig. 6). In fact, P2W18 was demonstrated to be as
potent as ouabain in inhibiting the Na+/K+-ATPase activity
(Table 2). The remaining studied POTs showed similar inhibitory
eﬀects in vitro and ex vivo. For example, the potential of TeW6 to
inhibit Ca2+-ATPase (IC50 value of 200 mM) was as low as its eﬀect
against Na+/K+-ATPase (inhibition of 10%; Table 2).
Both experiments (in vitro and ex vivo) clearly demonstrated
the high selectivity of Se2W29 for inhibiting the Ca
2+ pump due
to its rather sobering ex vivo results rendering this POT not the
best choice to target the Na+/K+-pump in vivo. The size (in terms
of volume and number of addenda atoms) of this large
POT could be one aspect aﬀecting the kinetics of its cellular
uptake, thus preventing the POT from targeting the enzyme.
The mechanisms of POT uptake and their permeation through
Fig. 4 Lineweaver–Burk plots of Ca2+-ATPase activity in the absence
(blue) and in the presence (orange) of 100 mM TeW6. The Anderson type
TeW6 presented a mixed type of enzyme inhibition. Data are plotted
as means  SD. The equations for linear fits are y = 0.0014x + 0.0124
(R2 = 0.9333) for control and y = 0.0026x + 0.0181 (R2 = 0.955) for TeW6.
The results shown are the average of triplicate experiments.
Fig. 5 The eﬀect of the Keggin type AsW9 applied in basolateral membranes
at a concentration of 10 mM is shown. Original trace of the eﬀect of short
circuit current (Isc, mA cm
2) in the opercular epithelium of killifish mounted in
Ussing chambers and kept under voltage clamp (Vt = 0 mV). Eﬀective time
50 (ET50) and maximum inhibitory eﬀects are calculated as the % of basal
values. Both parameters were calculated for three individual independent
experiments and used to generate Table 2. An arrow indicates the time of
POT application and consequently the time point zero. Time with negative
values represents stable basal control periods.
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epithelia still need to be clarified. The same selectivity pattern
for inhibition of Ca2+-ATPase activity (IC50 = 400 mM)
33 over Na+/
K+-ATPase (IC50 = 1.5 mM)
34 was shown in previous studies for
orthotungstate (HWO4
). Therefore, it seems that POT-mediated
inhibition is pump-specific and there is no POT structure that is
perfectly suited for all ion pumps in general. Moreover, the ex vivo
results show that not only the aﬃnity of the inhibitory compound
is relevant, but also how the POT gains access to the inhibition site
within an intracellular compartment, rendering the POT-Na+/
K+-ATPase interaction a complex one. The presented combination
of in vitro and ex vivo studies using two diﬀerent models to study
the eﬀects of POTs on the activity of ATPases indicates the
importance of establishing experimental conditions to be as close
to the physiological environment as possible.
The majority of P-type ATPase inhibitors in therapy target
the Na+/K+-ATPase.32,48 These compounds, which are used for
the treatment of several diseases such as heart failure, psychosis,
malaria and bacterial infection, show inhibitory capacities
resembling those of the here investigated POTs.48 Only a few
kinetic studies have been described so far testing POTs as
P-type ATPase inhibitors.24,32,42,46 The in vitro inhibition of
Na+/K+-ATPase by the Keggin POTs H3PW12O40 and H4SiW12O40
was previously described reporting IC50 values between 3 to
4 mM32 although information about the type of inhibition and
the mechanism of action are still lacking. In this study the
comparable IC50 value for the isostructural Keggin POT
CoW11Ti (IC50 = 4 mM) was observed.
Protein interactions and structure/function features of POTs
In order to decipher specific features of the nine POTs that are
responsible for the inhibition of Ca2+-ATPase, we correlated the
POT parameters like size and charge density with their IC50 values
of inhibition (Fig. 7A and B). No correlation was found when
considering all nine POTs and thus all determined IC50 values.
However, when taking only into account the high aﬃnity POTs,
exhibiting IC50 values lower then 16 mM, we observed a correlation
between their activity (IC50 value) and their charge density, which
was defined as charge of the POT divided by its number of W atoms
(Fig. 7A) as well as by the volume of POT anion (Fig. 7B). As can be
deduced from this data, POTs such as Se2W29 and P2W18 with a low
charge density (Fig. 7A and B) favored the inhibition of Ca2+-ATPase
activity indicating that besides electrostatic interactions also steric
interactions (depending on the shape complementarity between the
POT and the inhibition site) might play important roles in the
successful inhibition of Ca2+-ATPase.
For the ex vivo results (Na+/K+-ATPase) no correlation
between the ET50 values and POT charge density was observed.
Fig. 6 Inhibition (%) of the Na+/K+-ATPase from basal membrane of the
skin epithelia by two POTs P2W18 and Se2W29. The inhibition rate of P2W18
(1 mM) was 82% after 30 minutes (red), whereas for the most potent
Ca2+-ATPase inhibitor so far described, Se2W29 (IC50 = 0.3 mM), a minor
eﬀect (green) was observed (14% inhibition, after 30 minutes). Perpendicular
lines were used to calculate tissue resistance. As it can be observed, the
ex vivo epithelia preparations retained integrity and selectivity after POT
exposure.
Fig. 7 Structure–activity correlations of different POTs for ATPases inhibition. (A) Correlation between the IC50 values of five POTs (IC50 lower then
16 mM) of Ca2+-ATPase inhibition and their charge density expressed as charge of the POT divided by its number of W atoms. (B) Correlation between the
IC50 values of five POTs (IC50 lower then 16 mM) against Ca
2+-ATPase and the charge density expressed as charge of the POT divided by its volume
(in Å3). (C) Correlation between the percentage of maximum inhibition of four POTs (applied with the same concentration of 10 mM) against
Na+/K+-ATPase and POT size expressed as the length between the most distant atoms in the POT anion (in Å).
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However, a dependency of the maximum inhibition of four
POTs on their size, defined as length between the most distant
atoms in the POT anion was found (Fig. 7C).
POTs are also known to be strong kinase and phosphatase
inhibitors by acting through noncovalent interactions, which is
indispensable for the usage of POMs in the therapy of various
diseases.17–19,26,27 It was demonstrated that decavanadate V10
exhibits specific interactions with SR Ca2+-ATPase, which is
supposed to be non-competitive with respect to ATP and
induces protein cysteine oxidation with concomitant vanadium
reduction explaining the high inhibitory capacity of V10 (IC50 =
15 mM).24,33,47,48 The V10 binding site, which is formed by three
protein domains,47 is located at the cell cytoplasmatic side
(Fig. 8A). V10 can interact with proteins by electrostatic inter-
actions or by hydrogen bonding and the specific residues
involved in V10-SR Ca
2+-ATPase interaction still need to be
established, but might include the oxidized cysteine.24 In
contrast to monomeric vanadate, which only binds to the E2
conformation, V10 binds to all protein conformations, E1, E1P,
E2 and E2P,33 indicating the possibility of V10-ATPase interactions
at the extracellular side of the enzyme.48 The region where V10 is
expected to bind exhibits a positively charged surface and could
therefore also be addressed by other negatively charged POMs
(Fig. 8A).
Many drugs are known to act as ionic pumps inhibitors,
such as ouabain, omeprazole or thapsigargin, but only for some
of these compounds like ouabain the mechanisms and protein
binding sites were clearly established.32 According to structural
analysis, ouabain inhibits the Na+/K+-ATPase through binding
to a cavity formed by transmembrane helices (Fig. 8C, PDB
entry: 3A3Y).32 The binding sites for POMs are not known yet,
however, considering the structures of POMs and ouabain, it is
very unlikely that they share the same binding site (within the
neutral transmembrane area). Analysis of the electrostatic
(coulombic) surface of Na+/K+-ATPase reveals that both the
cytoplasmic and extracellular region of the enzyme possess
areas exhibiting a positive surface potential (Fig. 8B),31 which
could be addressed by the negatively charged POMs, the binding
sites of which need to be identified.
Conclusions
In general, polyoxometalates are able to inhibit phosphatases,
ecto-nucleotidases and P-type ATPases. Here, we demonstrated
that the Ca2+-ATPase activity from sarcoplasmic reticulum is
inhibited by several POTs. P2W18 was the most potent ATPase
inhibitor in this study as it exhibited the highest inhibitory
activity for the Na+/K+-ATPase (100% inhibition at 10 mM) and
the second highest for the Ca2+-ATPase (IC50 = 0.6 mM). A mixed
type of inhibition was observed for P2W18 and TeW6 suggesting
a diﬀerent mode of protein interaction with Ca2+-ATPase activity
than those observed for decavanadate and decaniobate (non-
competitive inhibitors). The most potent Ca2+-ATPase inhibitor
Se2W29 showed only limited eﬀects on the Na
+/K+-ATPase from
basal membrane of the skin epithelia demonstrating that some
POTs exhibit selectivity against certain ion pumps. The here
reported ex vivo model of Na+/K+-ATPase was used for the first
time to study the eﬀects of POTs on the processes of epithelial
chloride secretion, energized by the activity of the basolateral
Na+/K+-ATPase. Finally, we were able to derive structure–activity
relationships for high affinity POTs (IC50 o 16 mM) indicating
that the inhibition potential of the POTs is correlated with their
charge density, which will help to clarify their different inhibitory
activity. Polyoxotungstates are promising inorganic inhibitors of
P-type ATPases although their potential in vivo applications require
more studies and toxicological information.
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